Windlas Biotech Ltd.

View in App
355.05 -0.25 ▼-0.1%

29 September 2023, 04:01:00 PM
Volume: 2,251

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.windlasbiotech.com
Market Cap 741.26 Cr.
Enterprise Value(EV) 716.25 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 21.58 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 16.45 Trailing Twelve Months Ending 2023-06
Industry PE 38.47 Trailing Twelve Months Ending 2023-06
Book Value / Share 196.31 Trailing Twelve Months Ending 2023-06
Price to Book Value 1.81 Calculated using Price: 355.05
Dividend Yield 1.12 Period Ending 2023-03
No. of Shares Subscribed 2.08 Cr. 20,798,575 Shares
FaceValue 5
About Windlas Biotech Ltd.
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.

Windlas Biotech Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Windlas Biotech Ltd. Performance

View details >>
1 Day
-0.07%
1 Week
+0.45%
1 Month
-1.16%
3 Month
+16.35%
6 Month
+59.61%
1 Year
+53.30%
2 Year
-1.58%
5 Year
10 Year

Windlas Biotech Ltd. Fundamental Ratios

View details >>
6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 9.07 40.92 11.74 7.70 12.87 10.76
Return on Capital Employed (%) 14.54 40.49 15.05 9.93 14.88 14.39
Return on Assets (%) 3.83 22.01 7.45 4.97 9.70 8.39

Windlas Biotech Ltd. Balance Sheet

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 125 194 210 199 395 402
Non Curr. Liab. 21 8 3 4 0 3
Curr. Liab. 143 96 125 93 94 121
Minority Int.
Equity & Liab. 289 298 338 296 489 527
Non Curr. Assets 145 177 170 102 107 173
Curr. Assets 144 120 168 194 382 354
Misc. Exp. not W/O
Total Assets 289 298 338 296 489 527

Windlas Biotech Ltd. Profit and Loss

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 352 307 329 428 466 513 538
Other Income 4 4 2 3 7 10 10
Total Income 356 312 331 431 473 523 548
Total Expenditure -313 -269 -287 -373 -414 -453 -474
PBIDT 44 43 44 58 59 70 73
Interest -6 -5 -3 -1 -1 -1 -1
Depreciation -17 -11 -9 -13 -12 -12 -13
Taxation -9 -12 -8 -6 -7 -14 -15
Exceptional Items 50 -22
PAT 11 65 24 16 38 43 45
Minority Interest 0
Share Associate 0 -1 -7 0
Other Related Items
Consolidated Net Profit 11 64 16 16 38 43 45
Adjusted EPS 20 35 25 9 17 20 21

Windlas Biotech Ltd. Cash Flow

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 35 19 25 11 9 61
Cash Fr. Inv. -11 -5 -14 -20 -155 -14
Cash Fr. Finan. -26 -6 -5 1 130 -44
Net Change -2 7 5 -8 -15 3
Cash & Cash Eqvt 7 13 18 16 1 4

Windlas Biotech Ltd. Shareholding Pattern

View details >>
8 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 59.95 59.95 59.95 59.95 59.95 60.75 62.38 62.82
Public 40.05 40.05 40.05 40.05 40.05 39.25 37.62 37.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Windlas Biotech Ltd. Announcements

View details >>
Sat, 30 Sep 2023
Closure of Trading Window
Notice for Closure of Trading Window for Designated Persoons of the Company.
Fri, 22 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Wed, 13 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of 22nd AGM along with the scrutinisers report dated September 12 2023 enclosed.

Windlas Biotech Ltd. Technical Scans

View details >>
Fri, 29 Sep 2023
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Windlas Biotech Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 278,106.92 1,159.10 +2.4%
Divi's Laboratories Ltd. 99,942.28 3,761.95 +2.7%
Cipla Ltd. 95,813.38 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. 93,178.48 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. 73,867.93 5,149.95 +2.5%
Mankind Pharma Ltd. 71,831.52 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. 65,264.13 1,928.35 +3.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.97 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.60 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 30.87 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.76 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.76 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 56.04 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 51.80 1,928.35 +3.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.79 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.61 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 3.95 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.80 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.81 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.87 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.92 1,928.35 +3.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,928.35 +3.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,928.35 +3.4%

Windlas Biotech Ltd. FAQ's

What is Windlas Biotech share price?
Can I buy Windlas Biotech shares now?
What is the Dividend Yield of Windlas Biotech?
What is the Market Cap of Windlas Biotech?
What are the key metrics to analyse Windlas Biotech?
What is the 52 Week High and Low of Windlas Biotech?
What is the trend of Windlas Biotech share price?